"10.1371_journal.pone.0134437","plos one","2015-08-19T00:00:00Z","Manuel Sanchez-Alavez; William Nguyen; Simone Mori; Gianluca Moroncini; Andreu Viader; Daniel K Nomura; Benjamin F Cravatt; Bruno Conti","Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA, 92037, United States of America; Dipartimento di Scienze Cliniche e Molecolari, Universit√† Politecnica delle Marche, Ancona, Italy; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, 94720, United States of America","Conceived and designed the experiments: BC DN BFC AV. Performed the experiments: MSA WN SM. Analyzed the data: MSA BC. Contributed reagents/materials/analysis tools: BC GM BFC. Wrote the paper: BC DN AV BFC.","B.F.C. is a founder and advisor to Abide Therapeutics, a biotechnology company interested in developing serine hydrolase inhibitors and therapeutics. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","08","Manuel Sanchez-Alavez","MSA",8,TRUE,4,3,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
